Clinical Trial

Plaque Psoriasis

For adults (≥18) with moderate to severe plaque psoriasis (subcutaneous study drug)

Recruiting Trials

CLINICAL TRIAL

RECRUITING

Plaque Psoriasis

Trial

Trial ID: NCT06550076

Phase 3 | Oral tablet | 52 weeks


  • ≥ 18 years old

Learn More About This Trial

Contact Us